中国医药科学Issue(11)：190-191,2.
抗肿瘤血管生成联合介入治疗中晚期肝癌的临床观察
T he clinical efficacy of anti-angiogenesis therapy combined with interventional chemotherapy on middle and terminal liver cancer patients
郝代钧 1李伟 1樊建淑1
作者信息
- 1. 山东省青岛市肿瘤医院内二科，山东青岛266042
- 折叠
摘要
Abstract
Objective To explore the clinical efficacy of anti-angiogenesis therapy combined with interventional treatment on middle and terminal liver cancer patients.Methods A retrospective analysis of 139 cases patients with middle and terminal liver cancer from May 2009 to May 2012 in our hospital were divided into observation group(72 cases)and control group(67 cases). Observation group was treated with anti-tumor angiogenesis therapy combined with interventional chemotherapy and Control group was treated with only interventional chemotherapy. The clinical curative effect and Kamofsky score were observed and compared in both groups. Results(1)The rate of CR+PR in observation group was obviously higher than that in control group there was significant difference(P < 0.05);(2) After treatment, Kamofsky score in observation group was higher than that in control group, with significant difference (P<0.05). Conclusion The effect of anti-angiogenesis therapy combined with interventional treatment on middle and terminal liver cancer patients is better, is worthy of clinical application.关键词
抗肿瘤血管生成/中晚期肝癌/介入治疗Key words
Anti-angiogenesis therapy/Middle and terminal liver cancer/Interventional chemotherapy分类
医药卫生引用本文复制引用
郝代钧,李伟,樊建淑..抗肿瘤血管生成联合介入治疗中晚期肝癌的临床观察[J].中国医药科学,2013,(11):190-191,2.
